-antel
Drugs against parasitic worms.
- Drugs ending in -antel: 5
- Approved somewhere: 2
- With a US drug page: 2
- Stem
- -antel
- Class
- Drugs against parasitic worms
- Most common targets
- Voltage-activated calcium channel beta 1 subunit (1), Voltage-activated calcium channel beta 2 subunit (1)
Approved and clinical-stage drugs in ChEMBL whose names ending in -antel, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Praziquantel | Approved | Voltage-activated calcium channel beta 1 subunit, Voltage-activated calcium channel beta 2 subunit | Voltage-activated calcium channel beta 1 subunit blocker |
| Praziquantel, (r)- | Phase 3 | — | — |
| Pyrantel | Approved | — | — |
| Oxantel | Phase 2 | — | — |
| Monepantel | Phase 1 | — | Endoparasiticide for systemic use |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO